OR WAIT null SECS
Jill Wechsler is Pharmaceutical Technology's Washington Editor, jillwechsler7@gmail.com.
March 13, 2017
Trump’s choice for FDA commissioner faces drug pricing, regulatory, and approval challenges.
March 02, 2017
Policies limiting imports and immigration generate uncertainty for US and foreign firms
March 01, 2017
President Trump calls for faster FDA approvals and lower drug prices.
February 27, 2017
FDA plans to initiate its quality metrics program as industry continues to push back.
February 13, 2017
Drug companies are pushing Congress to action on funding for FDA programs and staff to expedite drug reviews and approvals.
February 02, 2017
User fee reauthorization is crucial to implementing the Cures Act and refining the approval process.